A number of case studies of HIV-1-infected individuals with NSCLC or malignant melanoma who were treated with nivolumab or ipilimumab (anti-CTLA4) reported changes in HIV-1 RNA or DNA [17–19,59]. The gene discussed is CTLA4; the disease is melanoma.